Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Titan Biotech has informed that the Board of Directors at its meeting held on September 03, 2026 had recommended Issuance of Bonus Equity Shares, subject to shareholders’ approval. The Shareholders of the Company subsequently approved the issuance of Bonus Equity Shares at 34th Annual General Meeting held on September 29, 2026. The Board of Directors the Company at its meeting held on October 26, 2026, has approved the allotment of 1,03,29,625 fully paid-up bonus equity shares of Rs. 2/- each in the ratio of 1:4 i.e. 1 new fully paid-up equity share of Rs. 2/- for every 4 existing fully paid-up equity share of Rs. 2/- to the eligible shareholders of the Company whose name appeared in the Register of Members/ Register of Beneficial Owners as on October 23, 2026, being the record date fixed for this purpose. The said Bonus Equity Shares would be credited to the Shareholders within the statutory time limits. Consequent to the aforesaid allotment, the paid-up Equity Share Capital of the Company shall stand increased from Rs. 8,26,37,000/- to Rs. 10,32,96,250 /-. The Board Meeting commenced at 09:30 AM and concluded at 09:55 AM.
The above information is a part of company’s filings submitted to BSE.
